Clinical trial

Repurposing Siponimod for Alzheimer's Disease

NCT06639282

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-08-26

PhasePHASE2

Study timeline

Study start (actual)2025-08-26Date precision: day

Registry last updated2026-03-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Alzheimer Diseaseunresolved

Mild Alzheimer Diseaseunresolved

MCI With Increased Risk for Alzheimer Diseaseunresolved

Cognitive Impairment, Mildunresolved

Interventions

SiponimodDRUG · verified · RxNorm: siponimod

Sponsors & collaborators

St. Joseph's Hospital and Medical Center, Phoenixlead sponsor

Texas Tech University Health Sciences Centercollaborator

Arizona State Universitycollaborator

National Institute on Aging (NIA)collaborator

Novartiscollaborator

Laboratory Corporation of Americacollaborator

Mapped research locations

PhoenixArizona, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06639282 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.